Clinical Trials for Biliary Tract Cancer

Find clinical trials for biliary tract cancer. Discover research opportunities and treatment options in your area.

71 Active Trials Found

Showing 71 trials on this page

Page 2 of 4

A Study of HRS-4642 Monotherapy or in Combination With Adebrelimab in the Treatment of Advanced Biliary Tract Tumors.

NCT ID: NCT06620848

This clinical trial is studying a new treatment option for patients with advanced biliary tract cancer, which affects the bile ducts. Researchers want to see how effective and safe a medication cal...

Recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, Shanghai, China

The Study of Association of Helicobacter Infections in Biliary Tract Cancers

NCT ID: NCT06909188

This clinical trial is studying the relationship between Helicobacter infections and biliary tract cancers, which include cancers of the gallbladder and bile ducts. Researchers want to find out how...

Not yet recruiting

Type: observational Locations: New Delhi, Delhi, India

Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors

NCT ID: NCT05784688

This clinical trial is studying a new treatment called TU2218 combined with Pembrolizumab for patients with advanced solid tumors, which are types of cancers that have spread and cannot be removed ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Seongnam, , Korea, Republic Of, Seoul, , Korea, Republic Of +10 more

A Post-marketing Observational Study of Tasfygo in Participants With Unresectable Biliary Tract Cancer With Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion Gene Positivity Who Progressed After Chemotherapy

NCT ID: NCT06793709

This clinical trial is looking at a medication called Tasfygo to see how safe it is for people with a specific type of cancer called unresectable biliary tract cancer. This type of cancer is challe...

Not yet recruiting

Type: observational

HX009+ IN10018 with or Without Standard Chemotherapy for Advanced Solid Tumours

NCT ID: NCT06708663

This clinical trial is exploring the effects of a new treatment called HX009 in combination with IN10018, with or without standard chemotherapy, for patients with advanced solid tumors, specificall...

Recruiting

Phase: PHASE1 Type: interventional Locations: Beijing, Beijing, China

Ligufalimab and Cadonilimab in Advanced Liver Cancers

NCT ID: NCT06789848

This clinical trial is exploring whether two drugs, Ligufalimab and Cadonilimab, can effectively treat advanced liver cancers, specifically hepatocellular carcinoma and biliary tract cancer, in pat...

Recruiting

Phase: PHASE2 Type: interventional Locations: Dallas, Texas, United States

CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative Chemotherapy Versus Immediate Resection in patIents With resecTable BiliarY Tract Cancers (BTC) at High Risk for Recurrence

NCT ID: NCT06037980

This clinical trial, called PURITY, is investigating whether a combination of three chemotherapy drugs—gemcitabine, cisplatin, and nab-paclitaxel—can help improve outcomes for patients with high-ri...

Recruiting

Phase: PHASE2 Type: interventional Locations: Monza, , Italy, Pavia, , Italy +17 more

Ambispective Cohort Study of Precision Medicine for Primary Hepatobiliary Cancer Based on Next-generation Sequencing

NCT ID: NCT05520788

This clinical trial is looking at new and personalized treatment options for patients with advanced liver and bile duct cancers, known as primary hepatobiliary cancers. Researchers want to see how ...

Recruiting

Type: observational Locations: Wuhan, Hubei, China

Early-stage Detection of LIver, Biliary TRAct and PancReatic Cancers

NCT ID: NCT06139042

The LIBRARY trial is a research study aimed at finding ways to detect liver, biliary tract, and pancreatic cancers early. Researchers are looking at different tests, including analyzing DNA from bl...

Recruiting

Type: observational Locations: Hangzhou, Zhejiang, China

XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies.

NCT ID: NCT06792435

This clinical trial is studying a new treatment called XNW27011 for patients with advanced cancers that have not responded to standard treatments. This includes types of cancer like pancreatic, lun...

Recruiting

Phase: PHASE1 Type: interventional Locations: 济南市, 山东省, China, 济南市, , China

Olaparib With or Without Durvalumab for DDR Gene Mutated Biliary Tract Cancer Following Platinum-based Chemotherapy

NCT ID: NCT05222971

This clinical trial is studying the effects of a combination treatment using two medications, olaparib and durvalumab, for patients with advanced biliary tract cancer that has specific genetic muta...

Recruiting

Phase: PHASE2 Type: interventional Locations: Seoul, , Korea, Republic Of

Adebrelimab With or Without SHR-8068 in Combination With Cisplatin Plus Gemcitabine as First-line Treatment in Patients With Advanced Biliary Tract Cancer

NCT ID: NCT06465563

This clinical trial is studying a new treatment approach for patients with advanced biliary tract cancer, which includes cancers of the bile ducts and gallbladder. Researchers want to see how well ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Hangzhou, Zhejiang, China

Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery

NCT ID: NCT06731998

This clinical trial is looking at how well different methods of managing pain work for patients undergoing minimally invasive surgery for various types of cancer. The study will compare three pain ...

Recruiting

Phase: NA Type: interventional Locations: Pittsburgh, Pennsylvania, United States

Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Biliary Tract Cancer Recurrence Surveillance

NCT ID: NCT06653127

This clinical trial is investigating a new way to monitor patients with biliary tract cancer, which is a type of cancer affecting the bile ducts. Researchers are looking at a specific marker in the...

Recruiting

Type: observational Locations: Wuhan, Hubei, China

A Single-arm, Open-label, Prospective Clinical Study of Surufatinib Combined With Immunotherapy and Chemotherapy for Unresectable or Metastatic Biliary Tract Cancer.

NCT ID: NCT06654947

This clinical trial is looking at a new treatment approach for patients with biliary tract cancer that cannot be surgically removed or has spread to other parts of the body. Researchers want to see...

Not yet recruiting

Phase: PHASE2 Type: interventional

Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors

NCT ID: NCT06451497

This clinical trial is researching a new treatment called ZM008, which is an experimental antibody designed to help fight certain advanced solid tumors, including various types of lung, breast, and...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Austin, Texas, United States +1 more

Chemoimmunotherapy Combined with Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer

NCT ID: NCT06546969

This clinical trial is studying a new treatment approach for patients with advanced biliary tract cancer, which includes types of cancer like cholangiocarcinoma. The goal is to see if combining sta...

Recruiting

Phase: PHASE1 Type: interventional Locations: Baltimore, Maryland, United States, Baltimore, Maryland, United States

Palliadelic Treatment to Reduce Psychological Distress in Persons With Advanced Gastrointestinal Cancers

NCT ID: NCT05220046

The Palliadelic Treatment trial is exploring whether psilocybin, a natural substance found in certain mushrooms, can help reduce psychological distress in people with inoperable pancreatic or bilia...

Recruiting

Phase: PHASE1 Type: interventional Locations: Omaha, Nebraska, United States

New Prospective Expanded German Registry of Incidental Gallbladder Carcinoma (PERSUASION)- a Permanent Platform Including All Kind of Biliary Tract Cancers (BTC)

NCT ID: NCT04896931

The PERSUASION trial is a clinical study that aims to gather information on different types of biliary tract cancers, including gallbladder cancer. This study will track the effectiveness of variou...

Recruiting

Type: observational Locations: Berlin, , Germany, Würzburg, Bayern, Germany +26 more

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

NCT ID: NCT04907643

This clinical trial is exploring how virtual reality (VR) can help manage severe abdominal pain in patients with digestive tract cancers. The study aims to find out if using immersive VR—where pati...

Recruiting

Phase: NA Type: interventional Locations: Los Angeles, California, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions